This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Indiana University, Ge Precision Healthcare LLC, Castle Biosciences, Incorporated. Active years: 2019-2026.
Company Filing History:
5 out of 804 
2 out of 1,391 
1 out of 6 
Years Active: 2019-2026
Title: Sunil Badve: Innovator in Cancer Diagnostics
Introduction
Sunil Badve is a prominent inventor based in Indianapolis, IN (US), known for his significant contributions to cancer diagnostics. With a total of 5 patents, Badve has focused on developing innovative methods and materials that enhance the understanding and treatment of various cancers.
Latest Patents
One of Badve's latest patents is titled "Materials and methods for diagnosing and predicting the course of prostate cancer." This invention involves the expression of Forkhead-box protein A1 (FOXA1), a transcription factor crucial for the normal development of the prostate gland. The study analyzed the expression of FOXA1, GATA-3, and androgen receptor (AR) in a series of 80 primary tumors and 28 metastatic prostate cancers. The findings revealed that high nuclear FOXA1 expression was present in 19% of primary tumors and 89% of metastatic tumors, indicating a strong correlation with tumor size and metastasis. This research suggests that FOXA1 expression can be a valuable marker for classifying patients at higher risk for metastatic prostate cancer.
Another notable patent by Badve is "Compositions for and methods of detecting, diagnosing, and prognosing thymic cancer." This invention provides biomarkers for detecting and diagnosing thymic cancer, along with kits for measuring the expression levels of these biomarkers. The methods outlined in this patent aim to improve the accuracy of diagnosing thymic cancer in individuals suspected of having the disease.
Career Highlights
Throughout his career, Sunil Badve has worked with esteemed institutions such as Indiana University and Castle Biosciences, Incorporated. His work has significantly impacted the field of cancer research and diagnostics, leading to advancements that benefit both patients and healthcare providers.
Collaborations
Badve has collaborated with notable colleagues, including Yesim Gokmen-Polar and Harikrishna Nakshatri. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in cancer diagnostics.
Conclusion
Sunil Badve's contributions to cancer diagnostics through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the understanding and treatment of cancer.